405
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Discriminating schizophrenia disease progression using a P50 sensory gating task with dense-array EEG, clinical assessments, and cognitive tests

, , , , , & show all
Pages 459-470 | Received 20 Dec 2018, Accepted 27 Mar 2019, Published online: 21 May 2019

References

  • Shetty S, Bose A. Schizophrenia and periodontal disease: an oro-neural connection? A cross-sectional epidemiological study. J Indian Soc Periodontol. 2014;18:69.
  • Andreasen N. Symptoms, signs, and diagnosis of schizophrenia. Lancet. 1995;346:477–481.
  • Cloutier M, Aigbogun MS, Guerin A, et al. The economic burden of schizophrenia in the United States in 2013. J Clin Psychiatry. 2016;77:764–771.
  • Larson MK, Walker EF, Compton MT. Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders. Expert Rev Neurother. 2010;10:1347–1359.
  • Insel TR. Rethinking schizophrenia. Nature. 2010;468:187–193.
  • Laursen TM. Life expectancy among persons with schizophrenia or bipolar affective disorder. Schizophr Res. 2011;131:101–104.
  • Zipursky RB, Reilly TJ, Murray RM. The myth of schizophrenia as a progressive brain disease. Schizophr Bull. 2012;39:1363–1372.
  • Rapoport JL, Gogtay N. Childhood onset schizophrenia: support for a progressive neurodevelopmental disorder. Int J Dev Neurosci. 2011;29:251–258.
  • Khamker N. First episode schizophrenia. S Afr Family Pract. 2015;57:29–33.
  • Fusar-Poli P, Bonoldi I, Yung AR, et al. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry. 2012;69:220–229.
  • Hartmann JA, Yuen HP, McGorry PD, et al. Declining transition rates to psychotic disorder in “ultra-high risk” clients: investigation of a dilution effect. Schizophr Res. 2016;170:130–136.
  • Yung AR, Yuen HP, Berger G, et al. Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull. 2007;33:673–681.
  • Haefner H, Maurer K. Early detection of schizophrenia: current evidence and future perspectives. World Psychiatry. 2006;5:130.
  • Fusar-Poli P, Borgwardt S, Bechdolf A, et al. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA psychiatry. 2013;70:107–120.
  • Yung AR. Treatment of people at ultra‐high risk for psychosis. World Psychiatry. 2017;16:207–208.
  • Valmaggia LR, Byrne M, Day F, et al. Duration of untreated psychosis and need for admission in patients who engage with mental health services in the prodromal phase. Br J Psychiatry. 2015;207:130–134.
  • American Psychiatric Association. American Psychiatric Association diagnostic and statistical manual. Washington (DC): American Psychiatric Association; 1980
  • Maercker A, Brewin CR, Bryant RA, et al. Proposals for mental disorders specifically associated with stress in the International Classification of Diseases-11. Lancet. 2013;381:1683–1685.
  • Miller TJ, McGlashan TH, Rosen JL, et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry. 2002;159:863–865.
  • Andreasen NC. A unitary model of schizophrenia: Bleuler’s fragmented phrene as schizencephaly. Arch Gen Psychiatry. 1999;56:781–787.
  • Kendler KS. Phenomenology of schizophrenia and the representativeness of modern diagnostic criteria. JAMA psychiatry. 2016;73:1082–1092.
  • Lawrie SM, Olabi B, Hall J, et al. Do we have any solid evidence of clinical utility about the pathophysiology of schizophrenia? World Psychiatry. 2011;10:19–31.
  • Smucny J, Olincy A, Eichman LC, et al. Early sensory processing deficits predict sensitivity to distraction in schizophrenia. Schizophr Res. 2013;147:196–200.
  • Van Tricht MJ, Nieman DH, Koelman JT, et al. Sensory gating in subjects at ultra high risk for developing a psychosis before and after a first psychotic episode. World J Biol Psychiatry. 2015;16:12–21.
  • Roth WT, Kopell BS. The auditory evoked response to repeated stimuli during a vigilance task. Psychophysiology. 1969;6:301–309.
  • Hamilton HK, Williams TJ, Ventura J, et al. Clinical and cognitive significance of auditory sensory processing deficits in schizophrenia. Am J Psychiatry. 2017;175:275–283.
  • Croft RJ, Lee A, Bertolot J, et al. Associations of P50 suppression and desensitization with perceptual and cognitive features of “unreality” in schizotypy. Biol Psychiatry. 2001;50:441–446.
  • Adler LE, Pachtman E, Franks R, et al. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry. 1982;17(6):639-654.
  • Clementz BA, Geyer MA, Braff DL. Poor P50 suppression among schizophrenia patients and their first-degree biological relatives. Am J Psychiatry. 1998;155:1691–1694.
  • Swerdlow NR, Geyer MA, Shoemaker JM, et al. Convergence and divergence in the neurochemical regulation of prepulse inhibition of startle and N40 suppression in rats. Neuropsychopharmacology. 2006;31:506.
  • Javitt DC, Freedman R. Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia. Am J Psychiatry. 2014;172:17–31.
  • Su L, Cai Y, Wang L, et al. Various effects of antipsychotics on p50 sensory gating in Chinese schizophrenia patients: a meta-analysis. Psychiatr Danub. 2012;24:44–50.
  • Myles-Worsley M. P50 sensory gating in multiplex schizophrenia families from a Pacific island isolate. Am J Psychiatry. 2002;159:2007–2012.
  • Owens E, Bachman P, Glahn DC, et al. Electrophysiological endophenotypes for schizophrenia. Harv Rev Psychiatry. 2016;24:129–147.
  • Braun U, Schäfer A, Bassett DS, et al. Dynamic brain network reconfiguration as a potential schizophrenia genetic risk mechanism modulated by NMDA receptor function. Proc Nat Acad Sci. 2016;113:12568–12573.
  • Rubinov M. Schizophrenia and abnormal brain network hubs. Dialogues Clin Neurosci. 2013;15:339.
  • Friston KJ. Dysfunctional connectivity in schizophrenia. World Psychiatry. 2002;1:66.
  • Insel T, Cuthbert B, Garvey M, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am Psychiatr Assoc. 2010;167:748–751.
  • Alexander-Bloch A, Lambiotte R, Roberts B, et al. The discovery of population differences in network community structure: new methods and applications to brain functional networks in schizophrenia. Neuroimage. 2012;59:3889–3900.
  • Mucha PJ, Richardson T, Macon K, et al. Community structure in time-dependent, multiscale, and multiplex networks. Science. 2010;328:876–878.
  • Cole MW, Bassett DS, Power JD, et al. Intrinsic and task-evoked network architectures of the human brain. Neuron. 2014;83:238–251.
  • Bassett DS, Wymbs NF, Porter MA, et al. Dynamic reconfiguration of human brain networks during learning. Proc Nat Acad Sci. 2011;108:7641–7646.
  • Braun U, Schäfer A, Walter H, et al. Dynamic reconfiguration of frontal brain networks during executive cognition in humans. Proc Nat Acad Sci. 2015;112:11678–11683.
  • Whitehead AL, Julious SA, Cooper CL, et al. Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Stat Methods Med Res. 2016;25:1057–1073.
  • Adler LE, Hoffer LD, Wiser A, et al. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry. 1993;150:1856.
  • Shiina A, Shirayama Y, Niitsu T, et al. A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia. Ann Gen Psychiatry. 2010;9:27.
  • Nuechterlein KH, Green MF, Kern RS, et al. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry. 2008;165:203–213.
  • Potkin SG, Alphs L, Hsu C, et al. Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial. Biol Psychiatry. 2003;54:444–452.
  • Miller TJ, McGlashan TH, Rosen JL, et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull. 2003;29:703–715.
  • Delorme A, Makeig S. EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci Methods. 2004;134:9–21.
  • Tadel F, Baillet S, Mosher JC, et al. Brainstorm: a user-friendly application for MEG/EEG analysis. Comput Intell Neurosci. 2011; 2011:8.
  • Pascual-Marqui RD. Standardized low-resolution brain electromagnetic tomography (sLORETA): technical details. Methods Find Exp Clin Pharmacol. 2002;24:5–12.
  • Xia M, Wang J, He Y. BrainNet Viewer: a network visualization tool for human brain connectomics. PloS one. 2013;8:e68910.
  • Desikan RS, Ségonne F, Fischl B, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31:968–980.
  • Lobier M, Siebenhühner F, Palva S, et al. Phase transfer entropy: a novel phase-based measure for directed connectivity in networks coupled by oscillatory interactions. Neuroimage. 2014;85:853–872.
  • Chen T, Guestrin C. Xgboost: A scalable tree boosting system. In: Proceedings of the 22nd ACM SIGKDD international conference on knowledge discovery and data mining. ACM; 2016. p. 785–794.
  • Oranje B, Glenthøj BY. Clonidine normalizes levels of P50 gating in patients with schizophrenia on stable medication. Schizophr Bull. 2013;40:1022–1029.
  • Lijffijt M, Lane SD, Meier SL, et al. P50, N100, and P200 sensory gating: relationships with behavioral inhibition, attention, and working memory. Psychophysiology. 2009;46:1059–1068.
  • Rekhi G, Ng WY, Lee J. Clinical utility of the Calgary Depression Scale for Schizophrenia in individuals at ultra-high risk of psychosis. Schizophr Res. 2018;193:423–427.
  • Roche E, Clarke M, Browne S, et al. Prevalence and clinical correlates of depression in the acute phase of first episode schizophrenia. Ir J Psychol Med. 2010;27:15–18.
  • Hausmann A, Fleischhacker W. Differential diagnosis of depressed mood in patients with schizophrenia: a diagnostic algorithm based on a review. Acta Psychiatr Scand. 2002;106:83–96.
  • Tregellas JR, Davalos DB, Rojas DC, et al. Increased hemodynamic response in the hippocampus, thalamus and prefrontal cortex during abnormal sensory gating in schizophrenia. Schizophr Res. 2007;92:262–272.
  • Williams TJ, Nuechterlein KH, Subotnik KL, et al. Distinct neural generators of sensory gating in schizophrenia. Psychophysiology. 2011;48:470–478.
  • Bak N, Rostrup E, Larsson HB, et al. Concurrent functional magnetic resonance imaging and electroencephalography assessment of sensory gating in schizophrenia. Hum Brain Mapp. 2014;35:3578–3587.
  • Korzyukov O, Pflieger ME, Wagner M, et al. Generators of the intracranial P50 response in auditory sensory gating. Neuroimage. 2007;35:814–826.
  • Huang M, Edgar J, Thoma R, et al. Predicting EEG responses using MEG sources in superior temporal gyrus reveals source asynchrony in patients with schizophrenia. Clin Neurophysiol. 2003;114:835–850.
  • Shenton ME, Dickey CC, Frumin M, et al. A review of MRI findings in schizophrenia. Schizophr Res. 2001;49:1–52.
  • Kasai K, Shenton ME, Salisbury DF, et al. Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia. Am J Psychiatry. 2003;160:156–164.
  • Hanlon FM, Miller GA, Thoma RJ, et al. Distinct M50 and M100 auditory gating deficits in schizophrenia. Psychophysiology. 2005;42:417–427.
  • Smucny J, Wylie K, Rojas D, et al. Evidence for gamma and beta sensory gating deficits as translational endophenotypes for schizophrenia. Psychiatry Res Neuroim. 2013;214:169–174.
  • Clementz BA, Blumenfeld LD, Cobb S. The gamma band response may account for poor P50 suppression in schizophrenia. Neuroreport. 1997;8:3889–3893.
  • Eckhorn R, Bauer R, Jordan W, et al. Coherent oscillations: A mechanism of feature linking in the visual cortex? Biol Cybern. 1988;60:121–130.
  • Tallon-Baudry C, Bertrand O. Oscillatory gamma activity in humans and its role in object representation. Trends Cogn Sci. 1999;3:151–162.
  • Meyer-Lindenberg A, Poline J-B, Kohn PD, et al. Evidence for abnormal cortical functional connectivity during working memory in schizophrenia. Am J Psychiatry. 2001;158(11):1809–1817.
  • Liang S, Hua H, Shenxun S, et al. Preliminary study of sensory gating P50 in diagnosis of schizophrenia. Shanghai Arch Psychiatry. 2010;22:133–135.
  • Peters RM, Gjini K, Templin TN, et al. A statistical methodology to improve accuracy in differentiating schizophrenia patients from healthy controls. Psychiatry Res. 2014;216:333–339.
  • Allen AJ, Griss ME, Folley BS, et al. Endophenotypes in schizophrenia: a selective review. Schizophr Res. 2009;109:24–37.
  • Taylor JA, Matthews N, Michie PT, et al. Auditory prediction errors as individual biomarkers of schizophrenia. NeuroImage Clin. 2017;15:264–273.
  • Chen C, Liu C-C, Weng P-Y, et al. Mismatch negativity to threatening voices associated with positive symptoms in schizophrenia. Front Hum Neurosci. 2016;10:362.
  • Molina V, Reig S, Sanz J, et al. Differential clinical, structural and P300 parameters in schizophrenia patients resistant to conventional neuroleptics. Prog Neuro Psychopharmacol Biol Psychiatry. 2008;32:257–266.
  • Louchart-de la Chapelle S, Nkam I, Houy E, et al. A concordance study of three electrophysiological measures in schizophrenia. Am J Psychiatry. 2005;162:466–474.
  • Mihalopoulos C, Harris M, Henry L, et al. Is early intervention in psychosis cost-effective over the long term? Schizophr Bull. 2009;35:909–918.
  • Cornblatt B, Obuchowski M, Roberts S, et al. Cognitive and behavioral precursors of schizophrenia. Dev Psychopathol. 1999;11:487–508.
  • Erlenmeyer-Kimling L, Rock D, Roberts SA, et al. Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York High-Risk Project. Am J Psychiatry. 2000;157:1416–1422.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.